Evaluating an Endocrine Therapy Dose-frequency Escalation Strategy and Its Effects on Tolerability and Compliance
Condition: Breast Cancer Interventions: Drug: Standard of care administration of Endocrine therapy; Drug: Dose-frequency escalation administration of Endocrine therapy Sponsor: Ottawa Hospital Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2023 Category: Research Source Type: clinical trials
Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients
Condition: Female Breast Cancer Interventions: Drug: Hormonal Antineoplastics; Drug: Chemotherapy drug Sponsor: Sohag University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2023 Category: Research Source Type: clinical trials
Evaluating an Endocrine Therapy Dose-frequency Escalation Strategy and Its Effects on Tolerability and Compliance
Condition: Breast Cancer Interventions: Drug: Standard of care administration of Endocrine therapy; Drug: Dose-frequency escalation administration of Endocrine therapy Sponsor: Ottawa Hospital Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2023 Category: Research Source Type: clinical trials
Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients
Condition: Female Breast Cancer Interventions: Drug: Hormonal Antineoplastics; Drug: Chemotherapy drug Sponsor: Sohag University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2023 Category: Research Source Type: clinical trials
Evaluating an Endocrine Therapy Dose-frequency Escalation Strategy and Its Effects on Tolerability and Compliance
Condition: Breast Cancer Interventions: Drug: Standard of care administration of Endocrine therapy; Drug: Dose-frequency escalation administration of Endocrine therapy Sponsor: Ottawa Hospital Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2023 Category: Research Source Type: clinical trials
Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients
Condition: Female Breast Cancer Interventions: Drug: Hormonal Antineoplastics; Drug: Chemotherapy drug Sponsor: Sohag University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2023 Category: Research Source Type: clinical trials
Evaluating an Endocrine Therapy Dose-frequency Escalation Strategy and Its Effects on Tolerability and Compliance
Condition: Breast Cancer Interventions: Drug: Standard of care administration of Endocrine therapy; Drug: Dose-frequency escalation administration of Endocrine therapy Sponsor: Ottawa Hospital Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2023 Category: Research Source Type: clinical trials
Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients
Condition: Female Breast Cancer Interventions: Drug: Hormonal Antineoplastics; Drug: Chemotherapy drug Sponsor: Sohag University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2023 Category: Research Source Type: clinical trials
Evaluating an Endocrine Therapy Dose-frequency Escalation Strategy and Its Effects on Tolerability and Compliance
Condition: Breast Cancer Interventions: Drug: Standard of care administration of Endocrine therapy; Drug: Dose-frequency escalation administration of Endocrine therapy Sponsor: Ottawa Hospital Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2023 Category: Research Source Type: clinical trials
Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients
Condition: Female Breast Cancer Interventions: Drug: Hormonal Antineoplastics; Drug: Chemotherapy drug Sponsor: Sohag University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2023 Category: Research Source Type: clinical trials
Evaluating an Endocrine Therapy Dose-frequency Escalation Strategy and Its Effects on Tolerability and Compliance
Condition: Breast Cancer Interventions: Drug: Standard of care administration of Endocrine therapy; Drug: Dose-frequency escalation administration of Endocrine therapy Sponsor: Ottawa Hospital Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2023 Category: Research Source Type: clinical trials
Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients
Condition: Female Breast Cancer Interventions: Drug: Hormonal Antineoplastics; Drug: Chemotherapy drug Sponsor: Sohag University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2023 Category: Research Source Type: clinical trials
Evaluating an Endocrine Therapy Dose-frequency Escalation Strategy and Its Effects on Tolerability and Compliance
Condition: Breast Cancer Interventions: Drug: Standard of care administration of Endocrine therapy; Drug: Dose-frequency escalation administration of Endocrine therapy Sponsor: Ottawa Hospital Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2023 Category: Research Source Type: clinical trials
Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients
Condition: Female Breast Cancer Interventions: Drug: Hormonal Antineoplastics; Drug: Chemotherapy drug Sponsor: Sohag University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2023 Category: Research Source Type: clinical trials
Evaluating an Endocrine Therapy Dose-frequency Escalation Strategy and Its Effects on Tolerability and Compliance
Condition: Breast Cancer Interventions: Drug: Standard of care administration of Endocrine therapy; Drug: Dose-frequency escalation administration of Endocrine therapy Sponsor: Ottawa Hospital Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2023 Category: Research Source Type: clinical trials
